Navigation Links
Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
Date:12/11/2007

Three-fold Lower Incidence of Severe Cardiac Toxicity With Equivalent

Complete Remission Rates Reported

ATLANTA, Dec. 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) announced today that preliminary data from its phase II/III randomized study comparing CPOP-R to CHOP-R in the first-line treatment of patients with aggressive non-Hodgkin's lymphoma (NHL) showed patients who received pixantrone experienced less severe (grade 3/4) toxicities including severe infection and febrile neutropenia when compared to patients treated with standard doxorubicin-based therapy. A preliminary analysis of the study, known as PIX203, which is ongoing, was presented at the American Society of Hematology (ASH) Annual Meeting in Atlanta.

"While preliminary, these randomized trial results are encouraging in supporting the preclinical findings that pixantrone is associated with a lower incidence of severe cardiac damage as evidenced by substantial declines in ejection fraction than standard anthracylines such as doxorubicin when administered as part of combination chemotherapy in the front line treatment of aggressive NHL," said Jack W. Singer, Chief Medical Officer of CTI. "Although preliminary, these data suggest that there may be reductions in other clinically important toxicities such as febrile neutropenia and severe infections without a loss in anti-tumor activity. These findings, along with its robust preclinical profile, suggest that pixantrone is an ideal drug candidate for further investigation in clinical trials for NHL, breast cancer and other diseases where anthracyclines are standard of care."

CHOP-R (cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab) Compared to CPOP-R (cyclophosphamide, pixantrone, vincristine, prednisone, rituximab) in 1st Line Therapy of Diffuse Large B cell Lymphoma (DLBCL): An Interim Analysis

Data were presented that show CPOP-R had comparable ant
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
5. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
8. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
9. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
10. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
11. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015  Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... offering of $60.0 million aggregate principal amount of ... in a private placement to qualified institutional buyers ... of 1933, as amended (the "Act"). Egalet also ...
(Date:4/1/2015)... -- Boston Scientific Corporation (NYSE: BSX ) will webcast a ... ET to review financial results and business highlights for the ... announcing first quarter financial results prior to the conference call. ... Mahoney , president and chief executive officer, and Dan ... A live webcast of the conference call will be ...
(Date:4/1/2015)... GLEN BURNIE, Md. , April 1, 2015 ... in patient recruitment solutions for the clinical research ... to help with a dermatology study that was ... its expert recruitment strategies and customized site support ... was screening and enrolling, and also increased the ...
Breaking Medicine Technology:Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results 2CSSi Quadruples Screening Activity and Speeds Enrollment for Pediatric Dermatology Study 2
... ACCESS PHARMACEUTICALS, INC. ... a biopharmaceutical company leveraging its proprietary drug-delivery platforms to ... and diabetes, reported it has been receiving ... MuGard for patients undergoing radiation and chemotherapy for various ...
... Inc. (Nasdaq: CHBT ) ("China-Biotics" or "the Company"), ... today reported its unaudited financial results for the third quarter and ... Third Quarter FY2011 ... y-o-y to $32.4 million; Bulk products sales increased ...
Cached Medicine Technology:Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 2Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 3Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 4China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 2China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 3China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 4China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 5China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 6China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 7China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 8China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 9China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 10China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011 11
(Date:4/2/2015)... 02, 2015 The Georgia ... Series on March 30th with speaker Gary ... , a leading provider of electronics manufacturing and ... Total Cost vs. Piece Price Manufacturing’, Bruce presented ... chain service and other postponement strategies. These developments ...
(Date:4/2/2015)... Angeles, CA (PRWEB) April 02, 2015 ... to provide users with a quick and easy means ... public earlier this week creating a buzz of excitement ... release has caught the attention of HonestyFirstReviews.com’s Tiffany Hendricks, ... “The buzz about Andrew and Chris Fox's new ...
(Date:4/2/2015)... Petersburg, FL (PRWEB) April 02, 2015 Grab ... inside scoop on all of the hottest trends with the ... airing on Wednesday, April 8th at 7:00 AM ET/PT, 6:00 ... Hosted by DRTV queen and marketing and product strategist Forbes ... lineup of celebrity guests as well as entrepreneurs, inventors, and ...
(Date:4/2/2015)... OAK HARBOR, WA (PRWEB) April 02, 2015 ... official launch of its new e-commerce-enabled website featuring ... and end-user focus on education and tools, and ... to provide access to the best in fluidics ... precision, convenience, and innovation, the new website’s robust ...
(Date:4/1/2015)... BMA Management, a leader in assisted ... name to Gardant Management Solutions this spring. , “The ... direction of our company and mirrors the optimistic, forward-looking ... potential we see,” said Rod Burkett, President and CEO ... place, the company remains committed to providing a dignified, ...
Breaking Medicine News(10 mins):Health News:Georgia Tech Manufacturing Institute Lunch Series Continues with Gary Bruce of PartnerTech 2Health News:Georgia Tech Manufacturing Institute Lunch Series Continues with Gary Bruce of PartnerTech 3Health News:Zapable - Review Examining Andrew and Chris Fox’s App Building Software System Released 2Health News:Forbes Living Showcases Trendsetters on Discovery Channel Transponder 2Health News:Forbes Living Showcases Trendsetters on Discovery Channel Transponder 3Health News:IDEX Health & Science Launches New Website with 4000+ Products 2Health News:IDEX Health & Science Launches New Website with 4000+ Products 3
... that a tiny, six-legged critter that suspends all biological ... to a better way to cryopreserve human eggs. ... heights or ocean depths as long as they have ... slowly dehydrate and essentially cease functioning until the rain ...
... plan in January next year that could make health insurance// ... that the plan also would target medical costs, hospital infections ... months, will be the latest health care initiatives that have ... Rendell wants to develop similar program for children, known as ...
... Child Development has proposed insurance cover for each girl child ... scheme, an insurance cover of one lakh rupees will be ... also to enable the girl to receive a lump sum ... Members of the Parliamentary Consultative Committee about the various welfare ...
... Specialists in Pediatric Nursing reveals the reasons //why children ... better treatment. ,According to the study, social ... are some of the reasons why children and adolescents ... Deficit-Hyeractivity Dsorder (ADHD). ,ADHD is a common ...
... in some autistic children by French scientists that may ... disorder.// Sequencing of a gene called SHANK3 in over ... revealed mutations in the gene in three families. SHANK ... proteins termed neuroligins which play a role in generating ...
... spread of MRSA has baffled experts and in a new ... a ruling that forbids Doctors//, and staff of hospitals, especially ... accessories- ties, scarves, wraps, watches, jewelry and the like. ... Brighton and Sussex University Hospitals NHS Trust, with an effort ...
Cached Medicine News:Health News:Durable Critters Provides Better Way to Human Egg Preservation 2Health News:Durable Critters Provides Better Way to Human Egg Preservation 3Health News:Durable Critters Provides Better Way to Human Egg Preservation 4Health News:Insurance Cover for Girl Child 2
... knee during surgery. Slotted base allows the ... knee surgery. Slots are also designed to allow ... can be sterilized by either gas or steam ... can be clamped over the sterile drape to ...
... Rod System offers the surgeon a simple ... rodding and plating. The rods are flexible, ... and enhanced healing4 The fluted non-reamed design ... into the canal. By requiring only one ...
Interphlex Flexible Stablization Rods offer correction of Hammer Toes with a High level of Flexibility while maintaining correct toe length and shape....
The True/Fix Compression Hip Screw System offers a wide variety of plate and screw sizes available....
Medicine Products: